Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: A European experience

Riccardo Lencioni, F. Pinto, N. Armillotta, A. M. Bassi, M. Moretti, M. Di Giulio, S. Marchi, M. Uliana, S. Della Capanna, M. Lencioni, C. Bartolozzi

Research output: Contribution to journalArticle

156 Citations (Scopus)

Abstract

The objective of our work was to evaluate the long-term results of percutaneous ethanol injection (PEI) for the treatment of hepatocellular carcinoma (HCC) in patients with liver cirrhosis. A total of 184 cirrhotic patients with HCC underwent PEI as the only anticancer treatment over an 8-year period. Patients were followed after therapy by means of clinical examinations, laboratory tests, and US and CT studies performed at regular time intervals. Survival rates were determined according to the Kaplan-Meier method. The overall survival was 67 % at 3 years, 41 % at 5 years, and 19 % at 7 years. The 3-, 5-, and 7-year survival rates of patients with single HCC ≤ 3 cm (78,54, and 28 %, respectively) were significantly higher (p <0.01) than those of patients with single HCC of 3.1-5 cm (61, 32, and 16, respectively) or multiple HCCs (51, 21, and 0 %, respectively). Survival of Child-Pugh A patients (79 % at 3 years, 53 % at 5 years, and 32 % at 7 years) was significantly longer (p <0.01) than that of Child-Pugh B patients (50 % at 3 years, 28 % at 5 years, and 8 % at 7 years). A selected group of 70 patients with Child-Pugh A cirrhosis and single HCC ≤ 3 cm had a 7-year survival of 42 %. Long-term survival of cirrhotic patients with HCC treated with PEI is comparable to that reported in published series of matched patients submitted to surgical resection.

Original languageEnglish (US)
Pages (from-to)514-519
Number of pages6
JournalEuropean Radiology
Volume7
Issue number4
StatePublished - 1997
Externally publishedYes

Fingerprint

Hepatocellular Carcinoma
Fibrosis
Ethanol
Injections
Therapeutics
Survival
Survival Rate
Liver Cirrhosis

Keywords

  • Alcohol
  • Interventional procedure
  • Liver neoplasms
  • Therapy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Lencioni, R., Pinto, F., Armillotta, N., Bassi, A. M., Moretti, M., Di Giulio, M., ... Bartolozzi, C. (1997). Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: A European experience. European Radiology, 7(4), 514-519.

Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis : A European experience. / Lencioni, Riccardo; Pinto, F.; Armillotta, N.; Bassi, A. M.; Moretti, M.; Di Giulio, M.; Marchi, S.; Uliana, M.; Della Capanna, S.; Lencioni, M.; Bartolozzi, C.

In: European Radiology, Vol. 7, No. 4, 1997, p. 514-519.

Research output: Contribution to journalArticle

Lencioni, R, Pinto, F, Armillotta, N, Bassi, AM, Moretti, M, Di Giulio, M, Marchi, S, Uliana, M, Della Capanna, S, Lencioni, M & Bartolozzi, C 1997, 'Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: A European experience', European Radiology, vol. 7, no. 4, pp. 514-519.
Lencioni R, Pinto F, Armillotta N, Bassi AM, Moretti M, Di Giulio M et al. Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: A European experience. European Radiology. 1997;7(4):514-519.
Lencioni, Riccardo ; Pinto, F. ; Armillotta, N. ; Bassi, A. M. ; Moretti, M. ; Di Giulio, M. ; Marchi, S. ; Uliana, M. ; Della Capanna, S. ; Lencioni, M. ; Bartolozzi, C. / Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis : A European experience. In: European Radiology. 1997 ; Vol. 7, No. 4. pp. 514-519.
@article{60d7b2bc3d574b74af86fc1e6584e8db,
title = "Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: A European experience",
abstract = "The objective of our work was to evaluate the long-term results of percutaneous ethanol injection (PEI) for the treatment of hepatocellular carcinoma (HCC) in patients with liver cirrhosis. A total of 184 cirrhotic patients with HCC underwent PEI as the only anticancer treatment over an 8-year period. Patients were followed after therapy by means of clinical examinations, laboratory tests, and US and CT studies performed at regular time intervals. Survival rates were determined according to the Kaplan-Meier method. The overall survival was 67 {\%} at 3 years, 41 {\%} at 5 years, and 19 {\%} at 7 years. The 3-, 5-, and 7-year survival rates of patients with single HCC ≤ 3 cm (78,54, and 28 {\%}, respectively) were significantly higher (p <0.01) than those of patients with single HCC of 3.1-5 cm (61, 32, and 16, respectively) or multiple HCCs (51, 21, and 0 {\%}, respectively). Survival of Child-Pugh A patients (79 {\%} at 3 years, 53 {\%} at 5 years, and 32 {\%} at 7 years) was significantly longer (p <0.01) than that of Child-Pugh B patients (50 {\%} at 3 years, 28 {\%} at 5 years, and 8 {\%} at 7 years). A selected group of 70 patients with Child-Pugh A cirrhosis and single HCC ≤ 3 cm had a 7-year survival of 42 {\%}. Long-term survival of cirrhotic patients with HCC treated with PEI is comparable to that reported in published series of matched patients submitted to surgical resection.",
keywords = "Alcohol, Interventional procedure, Liver neoplasms, Therapy",
author = "Riccardo Lencioni and F. Pinto and N. Armillotta and Bassi, {A. M.} and M. Moretti and {Di Giulio}, M. and S. Marchi and M. Uliana and {Della Capanna}, S. and M. Lencioni and C. Bartolozzi",
year = "1997",
language = "English (US)",
volume = "7",
pages = "514--519",
journal = "European Radiology",
issn = "0938-7994",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis

T2 - A European experience

AU - Lencioni, Riccardo

AU - Pinto, F.

AU - Armillotta, N.

AU - Bassi, A. M.

AU - Moretti, M.

AU - Di Giulio, M.

AU - Marchi, S.

AU - Uliana, M.

AU - Della Capanna, S.

AU - Lencioni, M.

AU - Bartolozzi, C.

PY - 1997

Y1 - 1997

N2 - The objective of our work was to evaluate the long-term results of percutaneous ethanol injection (PEI) for the treatment of hepatocellular carcinoma (HCC) in patients with liver cirrhosis. A total of 184 cirrhotic patients with HCC underwent PEI as the only anticancer treatment over an 8-year period. Patients were followed after therapy by means of clinical examinations, laboratory tests, and US and CT studies performed at regular time intervals. Survival rates were determined according to the Kaplan-Meier method. The overall survival was 67 % at 3 years, 41 % at 5 years, and 19 % at 7 years. The 3-, 5-, and 7-year survival rates of patients with single HCC ≤ 3 cm (78,54, and 28 %, respectively) were significantly higher (p <0.01) than those of patients with single HCC of 3.1-5 cm (61, 32, and 16, respectively) or multiple HCCs (51, 21, and 0 %, respectively). Survival of Child-Pugh A patients (79 % at 3 years, 53 % at 5 years, and 32 % at 7 years) was significantly longer (p <0.01) than that of Child-Pugh B patients (50 % at 3 years, 28 % at 5 years, and 8 % at 7 years). A selected group of 70 patients with Child-Pugh A cirrhosis and single HCC ≤ 3 cm had a 7-year survival of 42 %. Long-term survival of cirrhotic patients with HCC treated with PEI is comparable to that reported in published series of matched patients submitted to surgical resection.

AB - The objective of our work was to evaluate the long-term results of percutaneous ethanol injection (PEI) for the treatment of hepatocellular carcinoma (HCC) in patients with liver cirrhosis. A total of 184 cirrhotic patients with HCC underwent PEI as the only anticancer treatment over an 8-year period. Patients were followed after therapy by means of clinical examinations, laboratory tests, and US and CT studies performed at regular time intervals. Survival rates were determined according to the Kaplan-Meier method. The overall survival was 67 % at 3 years, 41 % at 5 years, and 19 % at 7 years. The 3-, 5-, and 7-year survival rates of patients with single HCC ≤ 3 cm (78,54, and 28 %, respectively) were significantly higher (p <0.01) than those of patients with single HCC of 3.1-5 cm (61, 32, and 16, respectively) or multiple HCCs (51, 21, and 0 %, respectively). Survival of Child-Pugh A patients (79 % at 3 years, 53 % at 5 years, and 32 % at 7 years) was significantly longer (p <0.01) than that of Child-Pugh B patients (50 % at 3 years, 28 % at 5 years, and 8 % at 7 years). A selected group of 70 patients with Child-Pugh A cirrhosis and single HCC ≤ 3 cm had a 7-year survival of 42 %. Long-term survival of cirrhotic patients with HCC treated with PEI is comparable to that reported in published series of matched patients submitted to surgical resection.

KW - Alcohol

KW - Interventional procedure

KW - Liver neoplasms

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=0030629507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030629507&partnerID=8YFLogxK

M3 - Article

C2 - 9204330

AN - SCOPUS:0030629507

VL - 7

SP - 514

EP - 519

JO - European Radiology

JF - European Radiology

SN - 0938-7994

IS - 4

ER -